HLA HEK293T cell transient overexpression lysate (as WB positive control)
Tag | C-Myc/DDK |
Expression Host | HEK293T |
HLA HEK293T cell transient overexpression lysate (as WB positive control)
Tag | C-Myc/DDK |
Expression Host | HEK293T |
Transient overexpression lysate of major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
Tag | C-Myc/DDK |
Expression Host | HEK293T |
HLA MS Standard C13 and N15-labeled recombinant protein (NP_002115)
Tag | C-Myc/DDK |
Expression Host | HEK293 |
HLA (untagged)-Human major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
Vector | pCMV6-XL5 |
Tag | Tag Free |
Mammalian Cell Selection | None |
HLA (untagged) - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 2
Vector | PCMV6-Neo |
Tag | Tag Free |
Mammalian Cell Selection | Neomycin |
USD 415.00
2 Weeks
HLA class II DR beta 1 / HLA-DRB1 mouse monoclonal antibody, clone MEM-267, PE
Applications | FC |
Reactivities | Human |
Conjugation | PE |
3' UTR clone of major histocompatibility complex class II DR beta 1 (HLA-DRB1) for miRNA target validation
Vector | pMirTarget |
Mammalian Cell Selection | Neomycin |
Species | Human |
Transfection Reporter | RFP |
Assay Reporter | Luciferase |
HLA-DRB1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
HLA-DRB1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
E. coli Selection | Ampicillin |
Mammalian Cell Selection | Puromycin |